UroGen Pharma to Present at June 2019 Investor Conferences

On May 30, 2019 UroGen Pharma Ltd. (Nasdaq:URGN), reported that management will present at three investor conferences in June (Press release, UroGen Pharma, MAY 30, 2019, View Source [SID1234536705]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Jefferies 2019 Global Healthcare Conference
Tuesday, June 4th
9:00AM Eastern Time
New York, NY
Goldman Sachs 40th Annual Global Healthcare Conference
Wednesday, June 12th
1:20PM Pacific Time
Rancho Palos Verdes, CA
Raymond James Life Sciences and MedTech Conference
Wednesday, June 19th
8:35AM Eastern Time
New York, NY
A live audio webcast of each event will be available on the Investors section of UroGen’s website, www.urogen.com. A replay of each webcast will be available on the website for approximately two weeks.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!